x min read

Stocks in Focus: Sprint Corporation (NYSE:S), EnteroMedics Inc. (NASDAQ:ETRM), Sinovac Biotech Ltd. (NASDAQ:SVA)

Stocks in Focus: Sprint Corporation (NYSE:S), EnteroMedics Inc. (NASDAQ:ETRM), Sinovac Biotech Ltd. (NASDAQ:SVA)
Written by
Blake Magnuson
Published on
October 15, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

Sprint Corporation (NYSE:S) and T-Mobile US Inc (TMUS) have asked the Federal Communications Commission (FCC) to scrutinize AT&T Inc.’s (T) recent low frequency spectrum purchases. On last trading day Sprint Corporation (NYSE:S) moved up 2.37% to close at $6.04. Its volatility for the week is 4.44% while volatility for the month is 3.63%. S's EPS growth for past 5 years was -73.48%. Sprint Corporation (NYSE:S) monthly performance is -12.97%.EnteroMedics Inc. (NASDAQ:ETRM) on 29 September 2014 announced that its CE mark for the Maestro rechargeable system for obesity has expanded to include the management of type 2 diabetes through improved glycemic control, according to a company press release. On last trading day EnteroMedics Inc. (NASDAQ:ETRM) moved up 5.88% to close at $1.08. Its volatility for the week is 6.13% while volatility for the month is 7.12%. ETRM's EPS growth for past 5 years was 48.90%. EnteroMedics Inc. (NASDAQ:ETRM) monthly performance is -16.28%.Sinovac Biotech Ltd. (NYSE:SVA) last released its earnings data on Thursday, August 14th. The company reported ($0.04) earnings per share for the quarter, missing the analysts’ consensus estimate of $0.01 by $0.05. The company had revenue of $12.10 million for the quarter, compared to the consensus estimate of $17.20 million. Analysts expect that Sinovac Biotech will post $-0.04 EPS for the current fiscal year. Sinovac Biotech Ltd. (NASDAQ:SVA) has 30.46% insider ownership while its institutional ownership stands at 47.00%. In last trading activity company's stock closed at $5.06.The Charles Schwab Corporation (NYSE:SCHW) is reporting for the quarter ending September 30, 2014. The investment bankers company's consensus earnings per share forecast from the 12 analysts that follow the stock is $0.25. This value represents a 13.64% increase compared to the same quarter last year. In the past year SCHW has met analyst expectations once and beat the expectations the other three quarters. Zacks Investment Research reports that the 2014 Price to Earnings ratio for SCHW is 26.22 vs. an industry ratio of 21.60, implying that they will have a higher earnings growth than their competitors in the same industry.The Charles Schwab Corporation (NYSE:SCHW) in last trading activity moved up 0.44% to close at $25.28. Company weekly performance is -11.24% while its quarterly performance stands at -8.27%. The Charles Schwab Corporation (NYSE:SCHW) is -18.45% away from its 52 week high.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.